Detalhe da pesquisa
1.
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
Nature
; 554(7690): 62-68, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29364867
2.
Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
Gastroenterology
; 160(1): 346-361.e24, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007300
3.
mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote KrasG12D-Induced Acinar-to-Ductal Metaplasia and Early Pancreatic Carcinogenesis.
Gastroenterology
; 160(5): 1755-1770.e17, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388318
4.
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
Gastroenterology
; 161(5): 1601-1614.e23, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34303658
5.
Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Expert Opin Ther Targets
; 25(1): 5-13, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33246383
6.
Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer.
Dev Cell
; 45(6): 696-711.e8, 2018 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29920275
7.
Single cell polarity in liquid phase facilitates tumour metastasis.
Nat Commun
; 9(1): 887, 2018 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29491397
8.
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.
Nat Med
; 20(11): 1340-1347, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25326799